Invention Publication
- Patent Title: ANTIVIRAL APPLICATION OF NUCLEOSIDE ANALOG OR COMBINATION FORMULATION CONTAINING NUCLEOSIDE ANALOG
-
Application No.: US17996430Application Date: 2021-04-16
-
Publication No.: US20230219993A1Publication Date: 2023-07-13
- Inventor: Yuanchao XIE , Gengfu XIAO , Yang HE , Leike ZHANG , Heji Akber AISA , Hualiang JIANG , Jingshan SHEN
- Applicant: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES , WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCE , XINJIANG TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY, CHINESE ACADEMIY OF SCIENCES , VIGONVITA LIFE SCIENCES CO., LTD.
- Applicant Address: CN Shanghai
- Assignee: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES,WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCE,XINJIANG TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY, CHINESE ACADEMIY OF SCIENCES,VIGONVITA LIFE SCIENCES CO., LTD.
- Current Assignee: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES,WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCE,XINJIANG TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY, CHINESE ACADEMIY OF SCIENCES,VIGONVITA LIFE SCIENCES CO., LTD.
- Current Assignee Address: CN Shanghai
- Priority: CN 2010313870.X 2020.04.20 CN 2010568329.3 2020.06.19 CN 2011035065.1 2020.09.27
- International Application: PCT/CN2021/087928 2021.04.16
- Date entered country: 2022-10-17
- Main IPC: C07H7/06
- IPC: C07H7/06 ; A61P31/14 ; A61P31/16
Abstract:
The present invention relates to an antiviral application of nucleoside analogs. Specifically, the present invention relates to uses of nucleoside analogs and a pharmaceutical composition thereof as: (a) inhibitors for inhibiting the replication of coronaviruses, influenza viruses, respiratory syncytial viruses, flaviviridae viruses, filoviridae viruses and/or porcine epidemic diarrhea virus (PEDV); and/or (b) medicines for treating and/or preventing and mitigating diseases caused by coronavirus, influenza virus, respiratory syncytial virus, flaviviridae virus, filoviridae virus and/or porcine epidemic diarrhea virus (PEDV) infections. The nucleoside analogs according to the invention may treat and/or prevent and mitigate respiratory infection, pneumonia
(COVID-19) and other related diseases caused by 2019 novel coronavirus infection.
(COVID-19) and other related diseases caused by 2019 novel coronavirus infection.
Public/Granted literature
- US11919923B2 Antiviral application of nucleoside analog or combination formulation containing nucleoside analog Public/Granted day:2024-03-05
Information query
